IXP to raise Rs.200-Cr life sciences-focused early-stage VC fund

IXP (Innovation Acceleration Platform), a Life Sciences Venture Capital firm backed by JV Ventures, has launched its first fund, ‘IXP Lifesciences Catalyst Fund’ to invest in early-stage companies.The fund is targeting a corpus of INR 200 crore, with a greenshoe option of INR 100 crore. It plans to create a portfolio of 20-25 companies in the life sciences segment across areas such as pharma, biotechnology, medical technology, specialty chemicals, agrotechnology, and nutraceuticals.Founded in 2023, IXP supports scientists and innovators on their entrepreneurial journey by providing capital, laboratory spaces and access to a network of entrepreneurs through IXP Venture Studio.